)
DocMorris (DOCM) investor relations material
DocMorris Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 external revenue grew 21.5% YoY in local currency; adjusted EBITDA reached CHF 0.6 million, achieving the 2026 breakeven target ahead of schedule.
Active customers increased by 1.5 million YoY to 13.1 million; 0.2 million were added in Q3, including above-average growth in new Rx customers.
Financial highlights
Q3 external revenue was CHF 342.7 million, up 21.4% reported and 21.5% in local currency; revenue was CHF 327.4 million, up 22.1% and 22.2%, respectively.
9M external revenue rose 13.6% reported to CHF 970.6 million, or 15.5% in local currency; revenue increased 14.5% to CHF 926.6 million, or 16.4% in local currency.
Q3 adjusted EBITDA was CHF 0.6 million, reaching targeted breakeven ahead of schedule.
Outlook and guidance
FY 2026 external revenue growth guidance raised to 12.5–15% from 9–13%; adjusted EBITDA guidance raised to better than minus CHF 10 million from minus CHF 10 million to minus CHF 17.5 million.
FY 2026 capital expenditure guidance remains below CHF 30 million; free cash flow breakeven target remains during 2027, with medium-term targets unchanged.
- Rx-led growth drove higher 2026 guidance; H2 EBITDA breakeven remains the target.DOCM
Global Markets Forum Conference - Strong Rx and Digital Services growth, improved EBITDA, and raised 2026 guidance.DOCM
Q2 2026 - Q2 revenue up 15%, Rx up 46%, Digital Services up 80%, with 1.1M more active customers.DOCM
Q2 2026 TU - Q1 2026 revenue up 10.7% with strong Rx and digital services growth; EBITDA breakeven on track.DOCM
Q1 2026 TU - Double-digit revenue and digital growth, margin gains, and Google partnership support 2026 EBITDA breakeven.DOCM
H2 2025 - 2025 revenue up 11.1%, digital services and Rx drive growth; EBITDA breakeven expected 2026.DOCM
Q4 2025 TU - CardLink-fueled eRx and TeleClinic growth drive recovery, with 2024 revenue up 5–10%.DOCM
H1 2024 - Q1 2025 revenue up 13.4%, Rx up 52.3%, and CHF 200m capital raise fully underwritten.DOCM
Q1 2025 TU - Revenue up 7%, non-Rx profitable, Teleclinic doubled, CHF 200m raise planned for Rx growth.DOCM
H2 2024
Next DocMorris earnings date
Next DocMorris earnings date
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)